Simuly develops AI models specialized in simulating human behavior and virtual societies to support market research and decision-making. Its technology can simulate responses from specific population segments and predict outcomes such as customer churn when companies change pricing or product interfaces. In 2024 research led by the CEO, Simuly reported that AI agents reproduced social-science survey responses with about 85% accuracy. The company gained early commercial traction with customers like CVS Health, which has used Simuly’s models to train agents on proprietary data and simulate user reactions to new in-store services and hard-to-reach patient groups. Simuly also partners with Gallup to incorporate real survey-derived population distribution data into its models. The firm plans to continue research and broaden adoption of simulation as a business-critical tool.

Total raised

$100M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2026